Krithi Rao Bindal

Krithi Rao Bindal, M.S., Ph.D., M.B.A. is the President and Founder of Aroga Biosciences, a pharmaceutical firm that specializes in regulatory writing and regulatory submission services from drug discovery to launch. Dr. Bindal is passionate about science, technology advancement, and effectively communicating science. She has experience in fields ranging from oncology to inflammatory diseases and more and approximately 20 years of experience in regulatory/biopharma development. She was selected as the Face of Biotechnology Development by San Diego Magazine, and Top Leader of Influence in Life Sciences and Top 40 Business Leaders Under 40 by San Diego Business Journal. Dr. Bindal also led Aroga Biosciences to prominence with selection as a Top 10 CRO of 2022 by PharmaTech Outlook Magazine, Top Regulatory Submission Firm 2023-2025 by Life Sciences Review, and Best Places to Work 2025 by San Diego Business Journal. Dr. Bindal serves as the Chair of Young Women in Bio San Diego, American Medical Writers Association AI Leadership Committee, Biocom CA Regulatory Affairs Committee, and on the Advisory Board of CureMatch.

Dr. Bindal completed her M.S. in Immunology from University of North Texas Health Science Center, Ph.D. from the University of Texas MD Anderson Cancer Center, and an M.B.A. From University of California San Diego, Rady School of Management.